The drug company that prospered without creating any drugs
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
Stay updated with breaking news from Robert Mclean. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
The new drug looked so promising — except for that one warning sign.
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
From homeless to housed, healthy and reintegrated back into society. That’s the goal of a rehabilitation program in Chula Vista. It’s finding success getting homeless people permanently off the streets and it’s led by a man who has been there.